Skip to main content
. 2011 Feb;336(2):575–585. doi: 10.1124/jpet.110.173260

TABLE 2.

Affinities of N-substituted BZT analogs in binding to the transporters for dopamine, norepinephrine, and serotonin, and M1 muscarinic, histamine H1, σ1, and σ2 receptors

Numbers are Ki values in nM with S.E.M. or 95% confidence limits.

Target GA 1-69 GA 2-50 GA 2-99 JHW 013
DAT 29.2 ± 3.24 13.2 ± 1.50 5.59 ± 0.619 24.6 ± 1.70
SERT 490 ± 56.4 3870 ± 135 4600 ± 680 1420 ± 116
NET 7350 ± 934 2130 ± 160 1420a ± 125 1640 ± 153
M1 3280 ± 221b 4020 ± 592b 1250 ± 138b 257 ± 28.9b
H1 333 ± 22.6c 218 ± 15.5c 240 ± 32.6c 48.3 ± 5.54
σ1 430 (385–479) 12.1 (10.9–13.5) 129 (110–150) 6.90 (6.31–7.57)
σ2 65.8 (50.8–85.1)d 18.1 (15.0–21.8)d 156 (111–219)d 25.9 (20.0–33.8)d

SERT, serotonin transporter; NET, norepinephrine transporter.

a

Data were published in Kulkarni et al., 2004.

b

Data were published in Robarge et al., 2000.

c

Data were published in Campbell et al., 2005.

d

The Ki values reported are from a [3H]DTG binding assay in which the data uniformly modeled better for two than one binding site. The Ki value for the higher affinity site is displayed. The obtained high-affinity site is the site recognized as the σ2 receptor, whereas the low-affinity site is currently not identified. Values for the low-affinity DTG site and their 95% confidence limits were as follows: GA 1-69, 14,600 (3860–55,000); GA 2-50, 6500 (2830–14,900); GA 2-99, 8490 (424–171,000); JHW 013, 12,100 (4280–34,000).